Common Contracts
2 similar Limited Use License Agreement contracts
LIMITED USE AGREEMENTLimited Use License Agreement • March 12th, 2008
IMPORTANT INSTRUCTIONS — READ CAREFULLY: This Limited Use License Agreement, together with the individual clone and library use limitations set forth on the BACPAC Resource Website (the “Limited Use Agreement”), constitute a legal agreement between you and your organization (collectively, “Recipient”) and Children’s Hospital & Research Center at Oakland (“CHRCO”) to use materials containing BAC and PAC genomic DNA library clones, owned or controlled by CHRCO, and any Unmodified Derivative (where “Unmodified Derivative” means substances created by the Recipient which constitute an unmodified functional subunit or product expressed by the original materials provided by CHRCO. Some examples include subclones of unmodified cell lines, purified or fractionated subsets of the original materials, proteins expressed by DNA/RNA supplied by CHRCO or monoclonal antibodies secreted by a hybridoma cell line) (together, the “Materials”), which are received by the Recipient solely to conduct experime
LIMITED USE AGREEMENTLimited Use License Agreement • June 8th, 2007
IMPORTANT INSTRUCTIONS — READ CAREFULLY: This Limited Use License Agreement, together with the individual clone and library use limitations set forth on the BACPAC Resource Website (the “Limited Use Agreement”), constitute a legal agreement between you and your organization (collectively, “Recipient”) and Children’s Hospital & Research Center at Oakland (“CHRCO”) to use materials containing BAC and PAC genomic DNA library clones, owned or controlled by CHRCO, and any Unmodified Derivative (where “Unmodified Derivative” means substances created by the Recipient which constitute an unmodified functional subunit or product expressed by the original materials provided by CHRCO. Some examples include subclones of unmodified cell lines, purified or fractionated subsets of the original materials, proteins expressed by DNA/RNA supplied by CHRCO or monoclonal antibodies secreted by a hybridoma cell line) (together, the “Materials”), which are received by the Recipient solely to conduct experime
